Sugi Predict

Sugi Predict / Compounds / SCHEMBL23213670

SCHEMBL23213670

SCHEMBL23213670

O=C(O)N1CC2(CC(N3CCC(c4ccccc4C4CCOCC4)CC3)CO2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 9/20 0.61
▸ CHRM1 P11229 9/20 0.61
▸ CHRM2 P08172 3/20 0.44
▸ CHRM5 P08912 1/20 0.35
▸ EPHX2 P34913 4/20 0.35
▸ TSHR P16473 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RBP4 P02753 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ CCNT1 O60563 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ CLK1 P49759 1/20 0.33
▸ CLK2 P49760 1/20 0.33
▸ CDK7 P50613 1/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ IRAK1 P51617 1/20 0.33
▸ CCNH P51946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23213668 1.00 CHRM4 (0.61) CHRM4CHRM1CHRM2CHRM5EPHX2
SCHEMBL23212969 0.88 CHRM4 (0.54) CHRM4CHRM1CHRM2CHRM5ALDH1A1
SCHEMBL30828944 0.88 CHRM4 (0.54) CHRM4CHRM1CHRM2CHRM5ALDH1A1
SCHEMBL23212972 0.88 CHRM4 (0.54) CHRM4CHRM1CHRM2CHRM5ALDH1A1
SCHEMBL23213612 0.88 CHRM4 (0.61) CHRM4CHRM1CHRM2CHRM5ALDH1A1
SCHEMBL23213614 0.88 CHRM4 (0.61) CHRM4CHRM1CHRM2CHRM5ALDH1A1
SCHEMBL23213834 0.85 CHRM4 (0.53) CHRM4CHRM1CHRM2CHRM5RBP4
SCHEMBL23213830 0.85 CHRM4 (0.53) CHRM4CHRM1CHRM2CHRM5RBP4
SCHEMBL23213673 0.85 CHRM4 (0.59) CHRM4CHRM1CHRM2CHRM5
SCHEMBL23213325 0.84 CHRM4 (0.59) CHRM4CHRM1CHRM2CHRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140959-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2024-05-02 — — US disclosed
US-11820778-B2 2-azaspiro[3.4]octane derivatives as M4 agonists NOVARTIS AG (CH) 2023-11-21 — — US disclosed
US-20220411435-A1 2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2022-12-29 — — US disclosed
US-20210130365-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2021-05-06 — — US disclosed
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240140959-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885
US-20210130365-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885
US-20220411435-A1 2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885
US-11820778-B2 2-azaspiro[3.4]octane derivatives as M4 agonists CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.